<qa>  What is the efficacy of infliximab in reducing the incidence ofThis study will evaluate the efficacy of infliximab in reducing the incidence of grade II-IV acute graft versus host disease by day 100 post-transplant in patients undergoing allogeneic hematopoietic stem cell transplant. 